We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Transcriptome Selection Reveals Tumor Genes

By Biotechdaily staff writers
Posted on 06 Aug 2003
Researchers have identified 57 genes linked to the growth of human tumor cells. More...
These genes were pinpointed as a result of transcriptome-scale selection, which was used to isolate genetic suppressor elements (GSEs) inhibiting breast carcinoma cell growth.

The information buried in the genome of an organism is extracted by the process of transcription in which the DNA sequence of a gene is transcribed into the sequence of a messenger RNA (mRNA). The primary steps of this process are mRNA initiation, elongation, and termination. These are coupled to a huge network of post-transcriptional events that mature the mRNA into a form that can be exported from the nucleus to the cytoplasm, where it will be translated into the protein product. The whole process of transcription from initiation to export from the nucleus is highly regulated to ensure the gene products are present only at a specific time or place, for example, at a particular stage of development or in a specific tissue. The corresponding body of transcripts present at any given moment is called the transcriptome.

The strategy employed by investigators at the University of Illinois at Chicago (UIC, USA), described in the July 22, 2003, issue of Cancer Cell, required cutting human DNA into tiny, random fragments; inserting the fragments into a mammalian cell using a vector; and inducing the fragments to express their genetic information. Some of the fragments proved to be biologically active by interfering with the function of the genes from which they were derived.

"Our strategy was validated by the fact that more than half of the genes we identified were already known to play key roles in the growth of cells or the development of cancers,” explained senior author Dr. Igor Roninson, professor of molecular genetics at the University of Illinois. "Many of the other genes, however, were not previously known to be involved in cell division and proliferation. In fact, the functions of some of these genes were entirely unknown. The genes we have identified clearly have the potential to serve as targets for novel therapeutics in the fight against cancer.”



Related Links:
University of Illinois

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.